Related Experiment Videos
In vitro effects of an immunostimulating bacterial lysate on human lymphocyte function.
G Lanzilli1, R Falchetti, M Tricarico
1Institute of Neurobiology and Molecular Medicine, Section of Molecular Medicine, National Research Council, Rome, Italy. giulia.lanzilli@artov.inmm.cnr.it
Summary
MLBL, an oral vaccine, activates human immune cells like lymphocytes and T cells. This immune stimulation helps combat respiratory infections by enhancing both humoral and cellular immunity.
Area of Science:
- Immunology
- Vaccinology
- Microbiology
Background:
- MLBL is an oral immunostimulant vaccine composed of bacterial lysates.
- It is used for respiratory tract infections caused by Gram-positive and Gram-negative bacteria.
- Prior research indicated MLBL stimulates humoral and cellular immune responses.
Purpose of the Study:
- To investigate the in vitro effects of MLBL on human lymphocyte functions.
- To elucidate the mechanisms of action underlying MLBL's immunostimulatory effects.
Main Methods:
- In vitro analysis of MLBL's impact on human lymphocytes.
- Evaluation of lymphocyte activation markers, including IL-2 receptor expression.
- Assessment of cytokine production (IL-2, IL-10, IL-12, IFN-gamma).
- Monitoring the generation of CD4+ and CD8+ effector T cells.
Main Results:
- MLBL activated the IL-2 receptor (IL-2Ralpha) on B, CD4+ T, and CD8+ T cells.
- It induced the synthesis of key cytokines: IL-2, IL-10, IL-12, and IFN-gamma.
- MLBL promoted the generation of CD4+ and CD8+ effector T cells.
Conclusions:
- MLBL enhances both humoral and cellular immunity by activating diverse immune cell subsets.
- Its therapeutic effects in respiratory infections are linked to direct immune cell activation and the generation of effector cells.
- MLBL demonstrates potential for managing acute and recurrent respiratory tract infections.